Literature DB >> 10845178

Involvement of drugs in sexual assault.

L Slaughter1.   

Abstract

OBJECTIVE: To obtain information about the relationship of alcohol and drug usage in victims of sexual assault, including the newly identified "date rape" drugs gamma hydroxybutyrate and flunitrazepam. STUDY
DESIGN: Analysis of urine samples with gas chromatography combined with mass spectrometry can identify alcohol and numerous other drugs with a high degree of specificity. This service was offered to rape treatment centers throughout the United States in May 1996; urine samples obtained from sexual assault victims suspected of drug use by history or physical examination were sent for testing at the discretion of the examiner.
RESULTS: As of March 1999, a total of 2,003 specimens were analyzed. Nearly two-thirds of the samples contained alcohol and/or drugs; the predominant substances found were alcohol, present in 63%, and marijuana, present in 30%. A substantial subset of the specimens was found to contain other illicit substances, frequently in combination. GHB and flunitrazepam were found in < 3% of the positive samples. Additionally, over the two-year study period, the use of these two drugs appeared to be declining.
CONCLUSION: These findings support prior data indicating that alcohol, marijuana and/or other drugs are important risk factors in sexual assault. Continued monitoring of drug use by victims of sex crimes is important, and programs that serve victims should modify protocols to reflect this.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845178

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  17 in total

1.  Drug-facilitated date rape.

Authors:  E Weir
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

Review 2.  Sexual assault: key issues.

Authors:  Beata Cybulska
Journal:  J R Soc Med       Date:  2007-07       Impact factor: 5.344

3.  Chemical submission: results of 4-year French inquiry.

Authors:  S Djezzar; F Questel; E Burin; S Dally
Journal:  Int J Legal Med       Date:  2008-10-17       Impact factor: 2.686

4.  Analysis of clinical forensic examination reports on sexual assault.

Authors:  Stefanie Jänisch; Hildrun Meyer; Tanja Germerott; Urs-Vito Albrecht; Yvonne Schulz; Anette Solveig Debertin
Journal:  Int J Legal Med       Date:  2010-02-25       Impact factor: 2.686

Review 5.  gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.

Authors:  Daniel Pardi; Jed Black
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice.

Authors:  Charles D Cook; Laura Biddlestone; Andrew Coop; Patrick M Beardsley
Journal:  Psychopharmacology (Berl)       Date:  2006-02-02       Impact factor: 4.530

7.  Substance use among women receiving post-rape medical care, associated post-assault concerns and current substance abuse: results from a national telephone household probability sample.

Authors:  Jenna L McCauley; Dean G Kilpatrick; Kate Walsh; Heidi S Resnick
Journal:  Addict Behav       Date:  2012-12-13       Impact factor: 3.913

Review 8.  Alcohol consumption and women's vulnerability to sexual victimization: can reducing women's drinking prevent rape?

Authors:  Maria Testa; Jennifer A Livingston
Journal:  Subst Use Misuse       Date:  2009       Impact factor: 2.164

Review 9.  Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.

Authors:  Lawrence P Carter; Daniel Pardi; Jane Gorsline; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2009-06-02       Impact factor: 4.492

10.  Precollege Predictors of Incapacitated Rape Among Female Students in Their First Year of College.

Authors:  Kate B Carey; Sarah E Durney; Robyn L Shepardson; Michael P Carey
Journal:  J Stud Alcohol Drugs       Date:  2015-11       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.